-
公开(公告)号:US20220275097A1
公开(公告)日:2022-09-01
申请号:US17623792
申请日:2019-07-02
Applicant: SHANGHAITECH UNIVERSITY
Inventor: Guang YANG , Pingdong TAO
Abstract: The present technology relates generally to compositions and methods of preventing or treating diseases associated with mutantleptin receptors, leptin deficiency or leptin dysfunction. The present technology also relates to administering the anti-leptin receptor antibodies in effective amounts to treat a subject suffering from, or predisposed to, a disease associated with mutant leptin receptors, obesity, leptin deficiency, leptin resistance, and/or hypoleptinemia.